| Oct 11 |
Nurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
|
| Oct 9 |
Nurix Therapeutics Announces Presentations at ACR Convergence 2024, the Annual Meeting of the American College of Rheumatology
|
| Oct 8 |
Nurix: An Attractive Early-Stage Biotech Play
|
| Sep 30 |
Nurix Therapeutics Announces Presentations at Discovery on Target Conference
|
| Sep 6 |
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
|
| Sep 5 |
Nurix Therapeutics, Inc. (NRIX): This Small-Cap Healthcare Stock Is A Good Buy Right Now
|
| Sep 4 |
Nurix Therapeutics: Promising Science, Major Collaborations, Undifferentiated Data
|
| Aug 29 |
Nurix Therapeutics to Participate in Upcoming Investor Conferences
|
| Aug 12 |
We're Not Very Worried About Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Rate
|
| Jul 25 |
How Much Upside is Left in Nurix Therapeutics (NRIX)? Wall Street Analysts Think 25.27%
|
